News

13.04.2015

EMSP represented at DIA Europe meeting

EMSP’s Director of External Affairs Christoph Thalheim represented our organisation at the Drug Information Association’s (DIA) meeting of European health stakeholders,…

“We need to hear your voice” –
EMSP’s Patients Survey

06.04.2015

https://youtube.com/watch?v=ozhRZg9Gk_M EMSP is kindly inviting people living with multiple sclerosis (MS) across Europe to complete our Voice of MS Patient…

“We need to hear your voice” –
EMSP’s Patients Survey

06.04.2015

https://youtube.com/watch?v=ozhRZg9Gk_M EMSP is kindly inviting people living with multiple sclerosis (MS) across Europe to complete our Voice of MS Patient…

23.03.2015

Estonian MS Society marks 25 years with advocacy event

EMSP’s members from the Estonian MS Society (ESMUL) have marked their 25th anniversary with a high-profile national conference attended by…

Estonian MS Society marks 25 years with advocacy event

23.03.2015

EMSP’s members from the Estonian MS Society (ESMUL) have marked their 25th anniversary with a high-profile national conference attended by…

Patients’ voice at EBC brain research seminar

04.03.2015

EMSP’s partners from the European Brain Council (EBC) have joined the efforts to boost research in the field of brain…

04.03.2015

Patients’ voice at EBC brain research seminar

EMSP’s partners from the European Brain Council (EBC) have joined the efforts to boost research in the field of brain…

Clinical Drug Trials in Pediatric MS: Issues, Challenges and Hopes

28.02.2015

by Jon Temme, MSIF Coordinating Consultant to the International Pediatric MS Study Group Many new medications to treat multiple sclerosis (MS) are…

Clinical Drug Trials in Pediatric MS: Issues, Challenges and Hopes

28.02.2015

by Jon Temme, MSIF Coordinating Consultant to the International Pediatric MS Study Group Many new medications to treat multiple sclerosis (MS) are…

1 54 55 56 57 58 67